Doxa AB Stock price

Equities

DOXA

SE0005624756

Investment Management & Fund Operators

Delayed Nasdaq Stockholm 07:59:52 2024-03-28 am EDT 5-day change 1st Jan Change
3.12 SEK -0.48% Intraday chart for Doxa AB -0.64% -8.37%
Sales 2021 10.9M 1.02M Sales 2022 5.3M 495K Capitalization 1.43B 133M
Net income 2021 76M 7.09M Net income 2022 -39M -3.64M EV / Sales 2021 223 x
Net cash position 2021 15.1M 1.41M Net cash position 2022 52.1M 4.86M EV / Sales 2022 259 x
P/E ratio 2021
19.6 x
P/E ratio 2022
-34.2 x
Employees 7
Yield 2021 *
-
Yield 2022
-
Free-Float 36.99%
More Fundamentals * Assessed data
Dynamic Chart
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Balder, Doxa Portfolio Company Sell Building Rights in Sweden for SEK1 Billion MT
Doxa AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Valsoia creates new market segment with first liquid vegetable egg AN
Doxa AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Doxa AB (OM:DOXA) completed the acquisition of Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders. CI
When the narrative is stronger than fundamentals on stock markets Our Logo
Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Serneke Receives Public Takeover Offer From Doxa MT
Doxa AB (OM:DOXA) made an offer to acquire Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders for SEK 1 billion. CI
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Lifco AB (OM:LIFCO B) acquired Doxa Dental Ab. CI
Lifco Signs Deal to Buy Doxa Dental for Q1 2023 Consolidation MT
More news
1 day-0.48%
1 week-0.64%
Current month+5.76%
1 month+4.17%
3 months-10.86%
6 months+11.43%
Current year-8.37%
More quotes
1 week
3.05
Extreme 3.05
3.28
1 month
2.81
Extreme 2.81
3.60
Current year
2.81
Extreme 2.81
3.60
1 year
2.65
Extreme 2.65
6.27
3 years
2.03
Extreme 2.03
18.40
5 years
1.83
Extreme 1.83
18.40
10 years
1.01
Extreme 1.01
18.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 40 21-12-31
Director of Finance/CFO 47 21-12-31
Members of the board TitleAgeSince
Director/Board Member 64 20-12-31
Director/Board Member 53 22-12-31
Chairman 53 20-12-31
More insiders
Date Price Change Volume
24-03-28 3.12 -0.48% 192,004
24-03-27 3.135 -0.16% 437,761
24-03-26 3.14 +1.13% 907,049
24-03-25 3.105 -1.90% 414,959
24-03-22 3.165 +0.80% 309,520

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT

More quotes
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
More about the company
  1. Stock
  2. Equities
  3. Stock Doxa AB - Nasdaq Stockholm